Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trial

doi:10.3748/wjg.v16.i25.3133

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 25

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7854)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-5) series.

Item

Count

PDF

650

HTML

6840

Figures (1-3)

193

Tables (1-5)

171

Sum=7854

Jul 7, 2010 (publication date) through Aug 24, 2024

Times Cited of This Article

Times Cited (80)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Jul 7, 2010; 16(25): 3133-3143
Published online Jul 7, 2010. doi: 10.3748/wjg.v16.i25.3133

Full Size Figure Download Figure

Figure 1 Disposition of patients as of clinical cut-off date January 2008. The intention to treat (ITT) population comprised 77 patients randomized to FOLFOX6 plus cetuximab and 74 randomized to FOLFIRI plus cetuximab. ¹Values based on all treated patients (n = 151). FOLFOX: 5-fluorouracil (5-FU) folinic acid (FA) and oxaliplatin; FOLFIRI: 5-FU FA and irinotecan; PD: Progressive disease; AE: Adverse event.

Citation: Ocvirk J, Brodowicz T, Wrba F, Ciuleanu TE, Kurteva G, Beslija S, Koza I, Pápai Z, Messinger D, Yilmaz U, Faluhelyi Z, Yalcin S, Papamichael D, Wenczl M, Mrsic-Krmpotic Z, Shacham-Shmueli E, Vrbanec D, Esser R, Scheithauer W, Zielinski CC. Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trial. World J Gastroenterol 2010; 16(25): 3133-3143
URL: https://www.wjgnet.com/1007-9327/full/v16/i25/3133.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i25.3133